R&D Roundup: Pharma gets in on the biotech boom
New Appointments at Makara Health
The implications for global pharma HQs and what the UK needs to do.
Second deal in weeks for innovative peptides-focused biotech
Leela Barham considers how the OMA has progressed since its launch.